TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31964219

Group type: EXPERIMENTAL
Intervention: Doxorubicin + Black Seed Oil (80 mg/kg/dose, divided into 3 doses for 1 week after each doxorubicin dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 40
Study: 30641335

Group type: EXPERIMENTAL
Intervention: Brief pain and smoking (BPS) cessation intervention
Number of subjects: 0
Study: 28202439

Group type: EXPERIMENTAL
Intervention: Inverse-HOMA-IR
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: HOMA2-%S
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: QUICKI
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Revised-QUICKI
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Matsuda
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gutt
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: OGIS
Number of subjects: 20
Study: 25376604

Group type: EXPERIMENTAL
Intervention: 3-meter walk test
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 6-meter walk test
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: First trial of 3-meter course
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: First trial of 6-meter course
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Second trial of 3-meter course
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Second trial of 6-meter course
Number of subjects: 136
Study: 23973701

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 6748

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 6748

Group type: EXPERIMENTAL
Intervention: ACEI/ARBs
Number of subjects: 6748
Study: 21819765

Group type: EXPERIMENTAL
Intervention: Microporous polysaccharide hemospheres (MPH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Untreated side (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MPH
Number of subjects: 40
Study: 19317823

Group type: EXPERIMENTAL
Intervention: Insulin dose calculated for 60 g CHO
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 70-g meal
Number of subjects: 31
Study: 16425964

Group type: EXPERIMENTAL
Intervention: Ciclesonide 1,280 microg (ex‐actuator, equivalent to 1,600 microg ex‐valve)
Number of subjects: 24
Study: 15058128

Group type: COMPARATOR
Intervention: BairHugger (forced air device)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: SunTouch (radiant warmer)
Number of subjects: 42
Study: 11336587

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 0
Study: 9723115

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Clozapine N-oxide (CNO)
Number of subjects: 8
Study: 8020524

Group type: EXPERIMENTAL
Intervention: Iomeprol 300 mgI/ml at 3 ml/s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iomeprol 200 mgI/ml at 3 ml/s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iomeprol 300 mgI/ml at 2 ml/s
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iomeprol 200 mgI/ml at 2 ml/s
Number of subjects: 0
Study: 2656071

Group type: EXPERIMENTAL
Intervention: Low salt intake (50 mmol/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Normal salt intake (150 mmol/day)
Number of subjects: 8
Study: 48773

Group type: EXPERIMENTAL
Intervention: Arrhythmia computer monitoring
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional monitoring with a rate-triggered alarm system
Number of subjects: 64
Study: 31916797

Group type: EXPERIMENTAL
Intervention: Firearm-specific lethal means safety intervention that deemphasized fear and emphasized temporariness
Number of subjects: 96

Group type: COMPARATOR
Intervention: Other firearm-specific lethal means safety interventions
Number of subjects: 96
Study: 30442323

Group type: EXPERIMENTAL
Intervention: Self-reported sleep duration (Pittsburgh Sleep Quality Index)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Actigraphic sleep duration
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Wake after sleep onset (WASO)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Sleep efficiency
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Bias in self-reporting
Number of subjects: 175
Study: 28110954

Group type: EXPERIMENTAL
Intervention: Standardized back school program
Number of subjects: 535

Group type: COMPARATOR
Intervention: Usual care (traditional back school)
Number of subjects: 535
Study: 26767235

Group type: EXPERIMENTAL
Intervention: Fascia Iliaca Compartment Block via suprainguinal approach (group S)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fascia Iliaca Compartment Block via infrainguinal approach (group I)
Number of subjects: 40
Study: 23411958

Group type: EXPERIMENTAL
Intervention: Cevimeline gargle
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo gargle
Number of subjects: 29
Study: 21467544

Group type: EXPERIMENTAL
Intervention: ATG-F group
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201
Study: 18348137

Group type: EXPERIMENTAL
Intervention: Joint Kinaesthesia (JK)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Knee extensor muscle torque
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Knee flexor muscle torque
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Joint Position Sense (JPS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: JK and muscle torque measurements
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: JPS test
Number of subjects: 20
Study: 16822112

Group type: EXPERIMENTAL
Intervention: GA referral plus 8 sessions of individual CB therapy
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: GA referral plus a cognitive‐behavioral (CB) workbook
Number of subjects: 231

Group type: COMPARATOR
Intervention: GA referral
Number of subjects: 231
Study: 12839616

Group type: EXPERIMENTAL
Intervention: Imiquimod cream, applied topically three times a week
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 12
Study: 10235527

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 24

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 24
Study: 8886299

Group type: EXPERIMENTAL
Intervention: Tryptophan-free amino acid mixture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control mixture
Number of subjects: 40
Study: 1698137

Group type: EXPERIMENTAL
Intervention: Diethylaminoethyl-dextran (3 g total) taken 30 min before a standard mixed test meal
Number of subjects: 8
Study: 6163165

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (300 mg to 600 mg orally for 3 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional fibrinolytic agents only (Control)
Number of subjects: 20
Study: 31226213

Group type: EXPERIMENTAL
Intervention: PFT-guided clopidogrel (n=755)
Number of subjects: 2527

Group type: EXPERIMENTAL
Intervention: Clopidogrel switched to prasugrel (n=511)
Number of subjects: 2527

Group type: COMPARATOR
Intervention: Prasugrel in control patients with HPR (n=188)
Number of subjects: 2527

Group type: EXPERIMENTAL
Intervention: Low platelet reactivity (LPR)
Number of subjects: 2527
Study: 27923158

Group type: EXPERIMENTAL
Intervention: 20mg/day rosuvastatin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 40mg/day atorvastatin
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combined 10mg/day atorvastatin with 10mg/day ezetimibe
Number of subjects: 61
Study: 25838505

Group type: EXPERIMENTAL
Intervention: Remote ischaemic conditioning (RIC)
Number of subjects: 139
Study: 24449008

Group type: EXPERIMENTAL
Intervention: Group S (sudden perturbation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group G (gradual perturbation)
Number of subjects: 0
Study: 22824447

Group type: EXPERIMENTAL
Intervention: SAAF‐T program (n = 252)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Attention control (n = 250)
Number of subjects: 502
Study: 19945284

Group type: EXPERIMENTAL
Intervention: Clever Balance Board (CBB) test
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Sharpened-Romberg test
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Single limb stance test
Number of subjects: 56
Study: 17391225

Group type: EXPERIMENTAL
Intervention: Combination of propofol (25 microg/kg per minute) and ketamine (25 microg/kg per minute)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Combination of propofol (25 microg/kg per minute) and ketamine (12.5 microg/kg per minute)
Number of subjects: 32
Study: 16286279

Group type: EXPERIMENTAL
Intervention: Right IMA anastomosed to left coronary artery system (Group A)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Right IMA anastomosed to right coronary artery system (Group B)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Off-pump CABG in Group B
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Patency of right IMA to coronary artery system
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Patency of left IMA vs right IMA
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Patency of left and right IMA anastomosis on beating heart in Group B
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Patency of right IMA anastomosis with or without off-pump technique in Group B
Number of subjects: 94
Study: 12036167

Group type: EXPERIMENTAL
Intervention: Valdecoxib 20 mg
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Valdecoxib 40 mg
Number of subjects: 406

Group type: COMPARATOR
Intervention: Oxycodone 10 mg/Acetaminophen 1,000 mg
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study: 10440879

Group type: EXPERIMENTAL
Intervention: Intravesical chemotherapy after transurethral resection
Number of subjects: 0
Study: 7598072

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (70g carbohydrate/d)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low-carbohydrate diet (10g carbohydrate/d)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 50g protein/d
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 70g protein/d
Number of subjects: 48
Study: 3135609

Group type: EXPERIMENTAL
Intervention: 1.4 g of pivampicillin plus 1.0 g of probenecid, taken once a day for five days
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole (400 mg) and trimethoprim (80 mg), single ten-tablet dose on the first day, two five-tablet doses on the second day, and two three-tablet doses for the next three to five days
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole (400 mg) and trimethoprim (80 mg), single ten-tablet dose on the first day and two five-tablet doses on the second day
Number of subjects: 119
Study: 31392896

Group type: EXPERIMENTAL
Intervention: Vision-related Mobility
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Vision-related Reading
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Vision-related Emotional
Number of subjects: 186
Study: 31657165

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES) applied to Dazhui (GV14) and Mingmen (GV4) for 30 min at 2 Hz/100 Hz, 20‐30 mA.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES) group.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no electrical current transmission).
Number of subjects: 80
Study: 28177209

Group type: EXPERIMENTAL
Intervention: Early-term preventive labor induction
Number of subjects: 279

Group type: COMPARATOR
Intervention: Standard management
Number of subjects: 279
Study: 26423742

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNSs) 500 kcal/d
Number of subjects: 1967

Group type: COMPARATOR
Intervention: Super Cereal Plus (SC+) 810 kcal/d
Number of subjects: 1967
Study: 21942363

Group type: COMPARATOR
Intervention: Immediate dental implants without any filling material around the implants (Group A)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Pure-phase multiporous beta-tricalcium phosphate (beta-TCP) packed into the bone gaps around the implants (Group B)
Number of subjects: 28
Study: 21293921

Group type: EXPERIMENTAL
Intervention: Adjuvant surgical oophorectomy during the luteal phase of the menstrual cycle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adjuvant surgical oophorectomy during the follicular phase of the menstrual cycle
Number of subjects: 0
Study: 18445665

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) therapy (66 microg/kg.d) for 2 years in group 3 (78 patients from group 1)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (group 1 and group 2 without GH therapy)
Number of subjects: 219
Study: 20069533

Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST), a 14-session group treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 0
Study: 16101937

Group type: EXPERIMENTAL
Intervention: Live Lactobacillus paracasei (LP33) - 5 x 10(9) colony-forming units/capsule, 2 capsules per day for 30 days
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Heat-killed Lactobacillus paracasei (LP33) - 5 x 10(9) colony-forming units/capsule, 2 capsules per day for 30 days
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo - 2 capsules per day for 30 days
Number of subjects: 90
Study: 12468781

Group type: EXPERIMENTAL
Intervention: Oral citicoline (500, 1000, and 2000 mg)
Number of subjects: 1372

Group type: EXPERIMENTAL
Intervention: Oral citicoline (2000 mg)
Number of subjects: 1372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1372
Study: 9740631

Group type: EXPERIMENTAL
Intervention: Previously immobilized limb after plaster removal
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Previously immobilized limb after 45 days of rehabilitation
Number of subjects: 7

Group type: COMPARATOR
Intervention: Contralateral limb after plaster removal
Number of subjects: 7

Group type: COMPARATOR
Intervention: Contralateral limb after 45 days of rehabilitation
Number of subjects: 7
Study: 8067216

Group type: EXPERIMENTAL
Intervention: Interpleural analgesia with bupivacaine 5 mg.ml‐1 and 5 microgram epinephrine, 30 ml bolus, continuous infusion at 7 ml/hour
Number of subjects: 32

Group type: COMPARATOR
Intervention: Epidural analgesia with bupivacaine 3.75 mg.ml‐1 and 5 microgram epinephrine, 5 ml bolus, continuous infusion at 5 ml/hour
Number of subjects: 32
Study: 3289648

Group type: EXPERIMENTAL
Intervention: Alprazolam 4 mg/day
Number of subjects: 102

Group type: COMPARATOR
Intervention: Chlormethiazole 3.072 g/day (equivalent to 8 g of the edisylate)
Number of subjects: 102
Study: 11399715

Group type: EXPERIMENTAL
Intervention: Mediflo spirometer (high WBimp)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Coach spirometer (low WBimp)
Number of subjects: 30
Study: 30683060

Group type: EXPERIMENTAL
Intervention: Pharmacist's medication review combined with a communication pathway to GPs and nursing home staff, facilitation of change in interprofessional cooperation, educational training, and a toolbox for implementation.
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Pharmacist's medication review and interprofessional cooperation measures.
Number of subjects: 760
Study: 29317015

Group type: EXPERIMENTAL
Intervention: BDP BAI 320 μg/day
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: BDP BAI 640 μg/day
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: BDP MDI 320 μg/day
Number of subjects: 425

Group type: COMPARATOR
Intervention: Placebo BAI
Number of subjects: 425

Group type: COMPARATOR
Intervention: Placebo MDI
Number of subjects: 425
Study: 25037985

Group type: EXPERIMENTAL
Intervention: Intensive supervision of physiotherapist for 1 month (2 days/week) - Group 1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Control of physiotherapist twice monthly (1 day/2 weeks) - Group 2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy individuals - Group 3
Number of subjects: 60
Study: 25405392

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 608
Study: 21667048

Group type: EXPERIMENTAL
Intervention: Cancer Care Intervention (CCI) plus usual care (n = 118)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Usual care only (n = 119)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Age, stage of cancer, and surgical removal of the tumor
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Post hoc analysis by cancer site and gender
Number of subjects: 237
Study: 20303323

Group type: EXPERIMENTAL
Intervention: 75 IU recombinant follicle-stimulating hormone (rFSH)/day
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Ongoing pregnancy
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Correlation with age
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Correlation with antral follicle count (AFC)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Correlation with ovarian volume
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Correlation with FSH
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Correlation with cycle length
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Body weight
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Antral follicle count (AFC)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: FSH
Number of subjects: 123
Study: 17354182

Group type: EXPERIMENTAL
Intervention: Adjuvant hypertonic glucose solution injections
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no adjuvant therapy)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Combined group
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 67
Study: 15371046

Group type: EXPERIMENTAL
Intervention: Paraffin bath treatment combined with hand exercise
Number of subjects: 17

Group type: COMPARATOR
Intervention: Exercise only (Control)
Number of subjects: 17
Study: 11591551

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (two 200-microg puffs bid; budesonide group, n = 19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Identical placebo (placebo group, n = 18)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (symptomatic group, n = 19)
Number of subjects: 37
Study: 9845852

Group type: COMPARATOR
Intervention: Placebo and US National Cholesterol Education Program step 1 diet
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo and step 2 diet
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg day‐1 and step 1 diet
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg day‐1 and step 2 diet
Number of subjects: 215
Study: 7990319

Group type: EXPERIMENTAL
Intervention: T‐activin
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group (no T‐activin)
Number of subjects: 182
Study: 3058228

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) for 10 or 28 days in Group I (77 patients with acute severe aplastic anemia)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) for 10 days in Group II (44 patients with moderate or chronic severe aplastic anemia)
Number of subjects: 150

Group type: COMPARATOR
Intervention: High-dose nandrolone decanoate for 3 months in Group II (44 patients with moderate or chronic severe aplastic anemia)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (ATG) in Group III (patients with various bone marrow failure syndromes)
Number of subjects: 150
Study: 30099209

Group type: EXPERIMENTAL
Intervention: Internet-delivered pain management program (Pain Course) with clinician support
Number of subjects: 490

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 490
Study: 28238465

Group type: EXPERIMENTAL
Intervention: Methadone maintenance treatment (MMT)
Number of subjects: 2448
Study: 26165391

Group type: EXPERIMENTAL
Intervention: Ibuprofen/Famotidine (800 mg ibuprofen and 26.6 mg famotidine, three times daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen/Famotidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 0
Study: 23794693

Group type: EXPERIMENTAL
Intervention: Facemask
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Tongue Plate
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 47
Study: 21048773

Group type: EXPERIMENTAL
Intervention: Walnut supplementation (15 g/day for 4 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no walnuts for 4 weeks)
Number of subjects: 30
Study: 18281378

Group type: EXPERIMENTAL
Intervention: GnRHa+E(2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GnRHa+E(2)+MPA
Number of subjects: 10

Group type: COMPARATOR
Intervention: GnRHa
Number of subjects: 10
Study: 16569732

Group type: EXPERIMENTAL
Intervention: Spironolactone (50 mg/d)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Amlodipine (2.5 mg/d)
Number of subjects: 37
Study: 12867226

Group type: EXPERIMENTAL
Intervention: Fexofenadine 180 mg alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fexofenadine 180 mg with alcohol (0.3 g/kg body weight)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hydroxyzine 50 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hydroxyzine 50 mg with alcohol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10559084

Group type: EXPERIMENTAL
Intervention: Omeprazole, 40 mg qd for 8 weeks
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 107
Study: 8559161

Group type: EXPERIMENTAL
Intervention: Patients with median mononeuropathy (MM)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Patients with MM and type II diabetes
Number of subjects: 414

Group type: COMPARATOR
Intervention: Sural or peroneal conduction abnormalities
Number of subjects: 414
Study: 1872197

Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate medicated Multiload MLCu250 IUD
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Multiload MLCu250 IUD
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no IUD)
Number of subjects: 29
Study: 6605682

Group type: COMPARATOR
Intervention: Fenbufen (600 or 900 mg daily)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Aspirin (3.6 g daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30758216

Group type: EXPERIMENTAL
Intervention: Chitosan-Curcuminoid mouthwash (CHI-CUR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (CHX)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vehicle formulation (chitosan and PEG 400)
Number of subjects: 30
Study: 27585808

Group type: EXPERIMENTAL
Intervention: Guided self-help intervention (based on problem-solving therapy)
Number of subjects: 16